Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company ...
Scribe Therapeutics, Inc. (Scribe), a biotechnology company pioneering highly engineered CRISPR technologies designed to reshape the treatment of disease by enabling earlier intervention, improved ...
Researchers developed a scalable platform combining high-throughput chemistry and live-cell screening to discover molecular ...
Major contributions include those in enzyme function, geometric representation theory, earthquake science, and more ...
Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company producing precision-engineered ...
Q4 2025 Earnings Call February 17, 2026 3:00 AM ESTCompany ParticipantsWilliam Lynch - Head of Investor RelationsEdmond Scanlon ...
Tolion Health AI, a digital health company developing personalized, preventive, and predictive artificial intelligence (AI) ...
FAYETTEVILLE, GA, UNITED STATES, February 15, 2026 /EINPresswire.com/ -- Continuous glucose monitoring is essential for ...
The pilot run achieved approximately 99% reaction conversion, 90% isolated yield, and 535 grams of NCT at 99.6% ...
Specialty Resins and Polymers Market Expected to Reach USD 146.90 Billion by 2033, Driven by Sustainability and ...
Catalysis is key to address today’s most pressing environmental and public health challenges; from pollutant degradation and clean water generation to ...
Nilmani Singh is a postdoctoral researcher at the University of Illinois Urbana-Champaign working with robotics and AI to improve laboratory automations. In this Postdoc Portrait, he shares how ...